STERIS buys Xodus Medical for USD 2.1 billion: what it means for STERIS stock
Published on 10/13/2026 at 03:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- STERIS signed a USD 2.1 billion agreement to acquire Xodus Medical on October 12, 2026.
- Xodus Medical is projected to generate USD 245.0 million in 2026 revenue and USD 135.0 million in adjusted EBIT.
- STERIS reported USD 1.5 billion in fiscal 2027 first-quarter revenue, up 7.3 percent year over year.
- The last Lang & Schwarz price was EUR 196.30 on October 12, 2026.
STERIS plc (ISIN IE00BFY8C754) signed a USD 2.1 billion agreement to acquire Xodus Medical on October 12, 2026, according to GlobeNewswire. The transaction would add a specialty surgical products business to STERIS's healthcare consumables portfolio and is expected to close by December 31, 2026.
Three dated developments and figures
On August 5, 2026, STERIS reported fiscal 2027 first-quarter revenue of USD 1.49 billion, up 7.30 percent year over year, according to GreekSoup. On October 1, 2026, a filing reported 228 STERIS shares withheld for taxes, as detailed by StockTitan. The October 12, 2026 Xodus agreement is the latest event, with a USD 2.1 billion purchase price and a projected USD 245.0 million of calendar 2026 revenue at Xodus Medical, per GlobeNewswire.
What does the deal mean for margins?
Xodus Medical is projected to contribute USD 135.0 million of adjusted EBIT in calendar 2026, giving the acquisition an adjusted EBIT margin of 55.10 percent based on the disclosed projections. The release identifies adjusted EBIT as a non-GAAP measure and says STERIS expects the transaction to support revenue growth, margins and adjusted earnings.
Upcoming dates and financing
GlobeNewswire states that the transaction is expected to close by December 31, 2026, subject to regulatory approvals and customary conditions. A November 6, 2026 earnings date is listed by GuruFocus. STERIS said the deal would be financed primarily with debt and that it would provide a revised fiscal 2027 outlook after closing.
Stock valuation and last euro quote
STERIS had a market capitalization of USD 21.3 billion on October 12, 2026, while its NYSE price was last at USD 218.98. The same quote showed a 52-week range of USD 195.14 to USD 269.44, putting the last NYSE price 18.73 percent below the high.
Last quoted price in euros
The last Lang & Schwarz quote stood at EUR 196.30 on October 12, 2026 at 10:58 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of STERIS stock.
STERIS plc stock facts
- Company: STERIS plc
- ISIN: IE00BFY8C754
- Ticker: STE
- Primary exchange: NYSE
- Last price Lang & Schwarz as of October 12, 2026 at 10:58 p.m. CEST: EUR 196.30
- Market capitalization: USD 21.3 billion as of October 12, 2026
- 52-week range: USD 195.14-269.44 as of October 12, 2026
- Sector / Industry: Healthcare / Medical - Specialties
Market context: Market report S&P 500.
